MedPath

Cefdinir

CEFDINIR CAPSULES USP

Approved
Approval ID

86c21cdd-8b94-f4dc-e053-2991aa0a51eb

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 20, 2025

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Cefdinir

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code68071-4856
Application NumberANDA065264
Product Classification
M
Marketing Category
C73584
G
Generic Name
Cefdinir
Product Specifications
Route of AdministrationORAL
Effective DateAugust 20, 2025
FDA Product Classification

INGREDIENTS (9)

CARBOXYMETHYLCELLULOSE CALCIUMInactive
Code: UTY7PDF93L
Classification: IACT
FD&C BLUE NO. 1Inactive
Code: H3R47K3TBD
Classification: IACT
D&C RED NO. 28Inactive
Code: 767IP0Y5NH
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
CEFDINIRActive
Quantity: 300 mg in 1 1
Code: CI0FAO63WC
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 4/22/2016

PRINCIPAL DISPLAY PANEL

PDP

DESCRIPTION SECTION

LOINC: 34089-3Updated: 4/21/2016

DESCRIPTION

Cefdinir capsules contains the active ingredient cefdinir, an extended- spectrum, semisynthetic cephalosporin, for oral administration. Chemically, cefdinir is [6R-[6α,7β(Z)]]-7-[[(2-amino-4 thiazolyl) (hydroxyimino) acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid. Cefdinir is a white to slightly brownish-yellow solid. It is slightly soluble in dilute hydrochloric acid and sparingly soluble in 0.1 M pH 7.0 phosphate buffer. The molecular formula is C 14H 13N 5O 5S 2 and the molecular weight is 395.42. Cefdinir has the structural formula shown below:

Cefdinir USP

Cefdinir capsules contain 300 mg of cefdinir and the following inactive ingredients: carboxymethylcellulose calcium; colloidal silicon dioxide; and magnesium stearate. The capsule shells contain D&C Red #28; FD&C Blue #1; FD&C Red #40; gelatin and titanium dioxide.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 4/21/2016

HOW SUPPLIED

Cefdinir capsules USP, 300 mg, size 0 capsules having blue cap imprinted twice with LUPIN (in black ink) and purple body imprinted twice with CEFDINIR (in white ink) containing off white to creamish granular slug, are available as follows:

NDC 68071-4856-7 BOTTLES OF 14

NDC 68071-4856-2 BOTTLES OF 20

Store the capsules at 20°-25°C (68°-77°F); [see USP Controlled Room Temperature].

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Cefdinir - FDA Drug Approval Details